ES8303336A1 - Procedimiento para la obtencion de 1,4-dihidropiridinas enlazadas en c-3. - Google Patents

Procedimiento para la obtencion de 1,4-dihidropiridinas enlazadas en c-3.

Info

Publication number
ES8303336A1
ES8303336A1 ES510253A ES510253A ES8303336A1 ES 8303336 A1 ES8303336 A1 ES 8303336A1 ES 510253 A ES510253 A ES 510253A ES 510253 A ES510253 A ES 510253A ES 8303336 A1 ES8303336 A1 ES 8303336A1
Authority
ES
Spain
Prior art keywords
carbon atoms
different
phenyl
alkyl
hydroxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES510253A
Other languages
English (en)
Other versions
ES510253A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES510253A0 publication Critical patent/ES510253A0/es
Publication of ES8303336A1 publication Critical patent/ES8303336A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 1,4-DIHIDROPIRIDINAS EN C-3, DE FORMULA (I), EN LA QUE R, R'', R , R >'', R , R >'', R , R >'', R , R >'', X, Y E Y'', PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE CONDENSACION DE ACIDOS 1,4-DIHIDROPIRIDINCARBOXILICOS, DE FORMULA (II) CON UN COMPUESTO DIFUNCIONAL DE FORMULA Z-X-Z'', EN LAS QUE Z Y Z'' PUEDEN SER HIDROXI, MERCAPTO O NR , SIENDO R HIDROGENO, ALQUILO O ARALQUILO; Y LOS DEMAS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE EFECTUA EN UN DISOLVENTE ORGANICO INERTE A UNA TEMPERATURA ENTRE 0 C Y 180 C. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO ANTIHIPERTENSIVOS, VASODILATADORES Y TERAPEUTICOS CEREBRALES Y CORONARIOS.
ES510253A 1980-11-13 1982-03-09 Procedimiento para la obtencion de 1,4-dihidropiridinas enlazadas en c-3. Expired ES8303336A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803042769 DE3042769A1 (de) 1980-11-13 1980-11-13 C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES510253A0 ES510253A0 (es) 1983-02-01
ES8303336A1 true ES8303336A1 (es) 1983-02-01

Family

ID=6116648

Family Applications (3)

Application Number Title Priority Date Filing Date
ES507080A Expired ES8206477A1 (es) 1980-11-13 1981-11-12 Procedimiento para la obtencion de 1,4-dihidropiridinas en- lazadas en c-3.
ES510254A Granted ES510254A0 (es) 1980-11-13 1982-03-09 Procedimiento para la obtencion de 1,4-dihidropiridinas enlazadas en c-3.
ES510253A Expired ES8303336A1 (es) 1980-11-13 1982-03-09 Procedimiento para la obtencion de 1,4-dihidropiridinas enlazadas en c-3.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES507080A Expired ES8206477A1 (es) 1980-11-13 1981-11-12 Procedimiento para la obtencion de 1,4-dihidropiridinas en- lazadas en c-3.
ES510254A Granted ES510254A0 (es) 1980-11-13 1982-03-09 Procedimiento para la obtencion de 1,4-dihidropiridinas enlazadas en c-3.

Country Status (16)

Country Link
EP (1) EP0052300B1 (es)
JP (1) JPS57109766A (es)
AT (1) ATE11773T1 (es)
AU (1) AU546605B2 (es)
CA (1) CA1179342A (es)
DD (1) DD201900A5 (es)
DE (2) DE3042769A1 (es)
DK (1) DK501881A (es)
ES (3) ES8206477A1 (es)
FI (1) FI813567L (es)
GR (1) GR76338B (es)
HU (1) HU186438B (es)
IL (1) IL64253A (es)
NO (1) NO813649L (es)
PT (1) PT73920B (es)
ZA (1) ZA817840B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
EP0145956A1 (de) * 1983-11-16 1985-06-26 Ciba-Geigy Ag Neue Amid-Verbindungen
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
IT1203900B (it) * 1987-04-15 1989-02-23 Lagor Spa Poli 1,4-diidro-2,6-dimetilpiridine 3,5-dicarbossilesteri utili come stabilizzanti termici per polimeri sintetici
IL91382A (en) * 1988-09-01 1995-06-29 Orion Yhtymae Oy Alkenyl or arylmethylene-substituted beta-diketones their preparation and pharmaceutical compositions containing them
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
US5185370A (en) * 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
EP1085863A1 (en) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Cross-reference to related applications
US6897305B2 (en) 1998-06-08 2005-05-24 Theravance, Inc. Calcium channel drugs and uses
US7101909B2 (en) 1998-10-12 2006-09-05 Theravance, Inc. Calcium channel drugs and uses
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795791A1 (de) * 1966-11-16 1975-06-19 Astra Ab Pyridinderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
ES507080A0 (es) 1982-08-16
ATE11773T1 (de) 1985-02-15
FI813567A7 (fi) 1982-05-14
ES8303337A1 (es) 1983-02-01
AU7711081A (en) 1982-05-20
HU186438B (en) 1985-07-29
JPS57109766A (en) 1982-07-08
DE3042769A1 (de) 1982-06-09
NO813649L (no) 1982-05-14
PT73920B (en) 1983-03-29
FI813567L (fi) 1982-05-14
ES510253A0 (es) 1983-02-01
IL64253A (en) 1985-03-31
DD201900A5 (de) 1983-08-17
PT73920A (en) 1981-12-01
DK501881A (da) 1982-05-14
ZA817840B (en) 1982-10-27
IL64253A0 (en) 1982-02-28
AU546605B2 (en) 1985-09-12
ES510254A0 (es) 1983-02-01
CA1179342A (en) 1984-12-11
DE3168955D1 (en) 1985-03-28
ES8206477A1 (es) 1982-08-16
GR76338B (es) 1984-08-04
EP0052300A1 (de) 1982-05-26
EP0052300B1 (de) 1985-02-13

Similar Documents

Publication Publication Date Title
ES8303336A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas enlazadas en c-3.
ZA81140B (en) Pyrimidine-2-sulphides and their s-oxides for use in medicine and methods of use therefor,pharmaceutical compositions containing them,processes for their preparation and such compounds when novel per se
DK624286A (da) Usymmetriske aromatiske alfa-hydroxythioethere og salte deraf samt deres fremstilling og anvendelse
DE3583872D1 (de) Dihydropyridin-derivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische zusammensetzungen, und verfahren zur herstellung dieser zusammensetzungen.
ZA85390B (en) Methylenediphosphonic acid derivatives,process for their preparation and antirheumatic pharmaceutical compositions in which they are present
GB2145720B (en) Pharmaceutical preparations containing flavene or thio-flavene derivatives, the use thereof, novel flavenes and thioflavenes, and processes for their mnnufacture
EP0034002A3 (en) Carboxamidine derivatives
ATE92048T1 (de) Chloranilin-derivate.
ATE9222T1 (de) 4,4-disubstituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln.
ATE16803T1 (de) Verfahren zur herstellung von 3-(n-arylamino)tetrahydrothiophen-2-on-derivaten.
ES483299A1 (es) Un procedimiento para la preparacion de derivados de benzo- diacepina
GB1475173A (en) Sulphur-containing compounds having amino and oxy groups